Director of the National Institute of Drug Abuse (NIDA) at the National Institutes of Health
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
"Despite some contentious discussions regarding the addictiveness of marijuana, the evidence clearly indicates that long-term marijuana use can lead to addiction. Indeed, approximately 9% of those who experiment with marijuana will become addicted... There is also recognition of a bona fide cannabis withdrawal syndrome (with symptoms that include irritability, sleeping difficulties, dysphoria, craving, and anxiety), which makes cessation difficult and contributes to relapse."
"Adverse Effects of Marijuana Use," New England Journal of Medicine, June 5, 2014
Experts PhD's and JD's (lawyers) with significant post-doctoral involvement in medical marijuana issues; judges who have presided over medical marijuana cases. [Note: Experts definition varies by site.]
Involvement and Affiliations:
Director, National Institute on Drug Abuse (NIDA) at the National Institutes of Health, May 2003-present
Member, Institute of Medicine, National Academy of Sciences
Former Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Director for Life Sciences, US Department of Energy's Brookhaven National Laboratory (BNL)
Former Associate Dean, Medical School, State University of New York (SUNY) at Stony Brook
Former Professor, Department of Psychiatry, State University of New York (SUNY) at Stony Brook
Former Assistant Professor, University of Texas Medical School
Recipient, International Prize, French Institute of Health and Medical Research
Recipient, Laughlin Fellowship Award, New York University, 1984